Innovative Randomized Trial Designs to Generate Stronger Evidence about Subpopulation Benefits and Harms [Methods Study], 2013-2018 (ICPSR 39527)
Research studies called clinical trials test treatments to see if they are safe and effective for patients. When designing clinical trials, researchers must plan to include enough patients with different traits for the study to have accurate results. Once the study starts, researchers must follow the plan. Sometimes, early results from a trial show that a group of patients with a certain trait may have more benefits or harms from the treatment than other groups. For example, the treatment may not work for patients with a history of heart disease. In the standard trial design, researchers can't change the plan to stop enrolling these patients once the trial starts.
In this study, the research team compared the standard trial design with more flexible approaches known as adaptive enrichment designs. These designs set up rules that allow researchers to change the study plan. For example, if early results show a treatment doesn't work for patients with heart disease, researchers can stop enrolling these patients in the trial. The team compared the trial designs using data from four completed trials.
To access the methods and software, please visit the AdaptiveDesignStreamlinedOptimizer GitHub.